Richard Gale

5.3k total citations · 1 hit paper
103 papers, 2.3k citations indexed

About

Richard Gale is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Richard Gale has authored 103 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Ophthalmology, 45 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Epidemiology. Recurrent topics in Richard Gale's work include Retinal Diseases and Treatments (51 papers), Retinal Imaging and Analysis (41 papers) and Retinal and Optic Conditions (34 papers). Richard Gale is often cited by papers focused on Retinal Diseases and Treatments (51 papers), Retinal Imaging and Analysis (41 papers) and Retinal and Optic Conditions (34 papers). Richard Gale collaborates with scholars based in United Kingdom, United States and Switzerland. Richard Gale's co-authors include Robert L. Johnston, Bruno Zuberbühler, Martin McKibbin, Sobha Sivaprasad, Manuel Saldaña, Faruque Ghanchi, Winfried M. K. Amoaku, Louise Downey, Sajjad Mahmood and Yit C. Yang and has published in prestigious journals such as Blood, Contemporary Sociology A Journal of Reviews and PLoS ONE.

In The Last Decade

Richard Gale

95 papers receiving 2.2k citations

Hit Papers

Defining response to anti-VEGF therapies in neovascular AMD 2015 2026 2018 2022 2015 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Defining response to anti-VEGF therapies in neovascular AMD
    2015 262 citations Winfried M. K. Amoaku, Usha Chakravarthy et al. Eye profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Gale United Kingdom 27 1.5k 1.2k 353 313 149 103 2.3k
Susan M. Downes United Kingdom 36 3.9k 2.5× 2.3k 1.9× 2.5k 7.0× 398 1.3× 340 2.3× 137 6.1k
Lisa S. Kearns Australia 24 691 0.4× 579 0.5× 546 1.5× 372 1.2× 63 0.4× 71 1.5k
Helena Lee United Kingdom 21 515 0.3× 401 0.3× 460 1.3× 69 0.2× 31 0.2× 69 1.4k
Julie Bergeron Canada 23 852 0.6× 533 0.4× 762 2.2× 134 0.4× 29 0.2× 66 2.4k
James C. Tan United States 22 776 0.5× 517 0.4× 273 0.8× 48 0.2× 38 0.3× 53 1.2k
Hanne Meijers‐Heijboer Netherlands 40 353 0.2× 186 0.2× 1.9k 5.3× 170 0.5× 93 0.6× 98 4.9k
Andrew Scott United Kingdom 17 555 0.4× 388 0.3× 274 0.8× 53 0.2× 33 0.2× 63 1.2k
Peter Wiedemann Germany 17 508 0.3× 426 0.4× 180 0.5× 28 0.1× 29 0.2× 71 978
Stephen Moore United States 23 167 0.1× 350 0.3× 1.5k 4.1× 76 0.2× 92 0.6× 53 2.5k
Edward Shaw United States 21 127 0.1× 826 0.7× 417 1.2× 1.3k 4.1× 27 0.2× 67 4.8k

Countries citing papers authored by Richard Gale

Since Specialization
Citations

This map shows the geographic impact of Richard Gale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Gale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Gale more than expected).

Fields of papers citing papers by Richard Gale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Gale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Gale. The network helps show where Richard Gale may publish in the future.

Co-authorship network of co-authors of Richard Gale

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Gale. A scholar is included among the top collaborators of Richard Gale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Gale. Richard Gale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kataoka, Keiko, Richard Gale, Xiaoxin Li, et al.. (2025). Simultaneous GA and CNV/MNV: incidence, characteristics, and treatments. Graefe s Archive for Clinical and Experimental Ophthalmology. 263(5). 1197–1212. 1 indexed citations
3.
4.
Chandra, Shruti, Sarega Gurudas, Ian Pearce, et al.. (2023). Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3. Eye. 38(7). 1301–1307. 2 indexed citations
5.
Chandra, Shruti, Sarega Gurudas, Ben Burton, et al.. (2023). Associations of presenting visual acuity with morphological changes on OCT in neovascular age-related macular degeneration: PRECISE Study Report 2. Eye. 38(4). 757–765. 6 indexed citations
6.
7.
Diaz‐Pinto, Andres, Nishant Ravikumar, Avan Suinesiaputra, et al.. (2022). Predicting myocardial infarction through retinal scans and minimal personal information. Nature Machine Intelligence. 4(1). 55–61. 56 indexed citations
8.
Hariprasad, Seenu M., et al.. (2022). An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review. Ophthalmology and Therapy. 11(3). 959–982. 20 indexed citations
9.
10.
Ghanchi, Faruque, Sobha Sivaprasad, Konstantinos Balaskas, et al.. (2019). Acceptability of OCT angiography: A multicentre OCT Angiography NEtwork (OCTANE) study. Investigative Ophthalmology & Visual Science. 60(9). 3477–3477. 1 indexed citations
11.
Gale, Richard, Sajjad Mahmood, Praveen J. Patel, et al.. (2019). Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service. Eye. 33(S1). 1–21. 45 indexed citations
12.
Rattray, Ivan, Edward J. Smith, William R. Crum, et al.. (2017). Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington’s Disease. PLoS ONE. 12(1). e0168556–e0168556. 19 indexed citations
13.
Purnell, Thomas, Hayley E. Tyrer, Andrew Parker, et al.. (2017). A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways. PLoS Genetics. 13(8). e1006969–e1006969. 24 indexed citations
14.
Gale, Richard, Peter H. Scanlon, Marc Evans, et al.. (2017). Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease. Eye. 31(S1). S1–S20. 33 indexed citations
15.
Amoaku, Winfried M. K., Usha Chakravarthy, Richard Gale, et al.. (2015). Defining response to anti-VEGF therapies in neovascular AMD. Eye. 29(6). 721–731. 262 indexed citations breakdown →
16.
Inglehearn, Chris F., Manir Ali, Richard Gale, et al.. (2012). Improved Response To Ranibizumab In Ex And Current Smokers With Age-related Macular Degeneration (AMD), But No Evidence That CFH, ARMS2/HTRA1 Or VEGF Genotypes Predict Treatment Outcome. Investigative Ophthalmology & Visual Science. 53(14). 3325–3325. 3 indexed citations
17.
Gale, Richard, et al.. (2004). National Biometry Audit. Eye. 18(1). 63–66. 17 indexed citations
18.
Grant, Jon E. & Richard Gale. (1990). How to court a clinician.. PubMed. 100(5198). 628–9. 1 indexed citations
19.
Gale, Richard & Marc L. Miller. (1987). Comparing Coastal Spheres in Oregon and Washington. 868–882. 1 indexed citations
20.
Gale, Richard. (1969). Industrial Development and the Blue-Collar Worker in Argentina. International Journal of Comparative Sociology. 10(1). 117–150. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan M. Downes Breakdown of academic impact, for papers by Lisa S. Kearns Breakdown of academic impact, for papers by Helena Lee Breakdown of academic impact, for papers by Julie Bergeron Breakdown of academic impact, for papers by James C. Tan Breakdown of academic impact, for papers by Hanne Meijers‐Heijboer Breakdown of academic impact, for papers by Andrew Scott Breakdown of academic impact, for papers by Peter Wiedemann Breakdown of academic impact, for papers by Stephen Moore Breakdown of academic impact, for papers by Edward Shaw
Rankless by CCL
2026